CoChat

Human hypoimmune primary pancreatic islets avoid rejection and autoimmunity and alleviate diabetes in allogeneic humanized mice

Hu, Xiaomeng, Gattis, Corie, Olroyd, Ari G., Friera, Annabelle M., White, Kathy, Young, Chi, Basco, Ron, Lamba, Meghan, Wells, Frank, Ankala, Ramya, Dowdle, William E., Lin, August, Egenberger, Kyla, Rukstalis, J. Michael, Millman, Jeffrey R., Connolly, Andrew J., Deuse, Tobias, Schrepfer, Sonja · 2023 · Science Translational Medicine
Cited by 99

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Transplantation of allogeneic pancreatic donor islets has successfully been performed in selected patients with difficult-to-control insulin-dependent diabetes and impaired awareness of hypoglycemia (IAH). However, the required systemic immunosuppression associated with this procedure prevents this cell replacement therapy from more widespread adoption in larger patient populations. We report the editing of primary human islet cells to the hypoimmune HLA class I– and class II–negative and CD47-overexpressing phenotype and their reaggregation into human HIP pseudoislets (p-islets). Human HIP p-islets were shown to survive, engraft, and ameliorate diabetes in immunocompetent, allogeneic, diabetic humanized mice. HIP p-islet cells were further shown to avoid autoimmune killing in autologous, diabetic humanized autoimmune mice. The survival and endocrine function of HIP p-islet cells were not impaired by contamination of unedited or partially edited cells within the p-islets. HIP p-islet cells were eliminated quickly and reliably in this model using a CD47-targeting antibody, thus providing a safety strategy in case HIP cells exert toxicity in a future clinical setting. Transplantation of human HIP p-islets for which no immunosuppression is required has the potential to lead to wider adoption of this therapy and help more diabetes patients with IAH and history of severe hypoglycemic events to achieve insulin independence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.adg5794

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 99

Metadata

Authors
Hu, X., Gattis, C., Olroyd, A. G., Friera, A. M., White, K., Young, C., Basco, R., Lamba, M., Wells, F., Ankala, R., Dowdle, W. E., Lin, A., Egenberger, K., Rukstalis, J. M., Millman, J. R., Connolly, A. J., Deuse, T., & Schrepfer, S.
Venue
Science Translational Medicine
Published
2023-04-12
Volume
15
Issue
691
Pages
eadg5794-eadg5794
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W4365139883
Cited by
99
References
25
FWCI
23.61
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human hypoimmune primary pancreatic islets avoid rejection and autoimmunity and alleviate diabetes in allogeneic humanized mice. https://app.cochat.ai/papers/10.1126/scitranslmed.adg5794
The paper
Hu, X., Gattis, C., Olroyd, A. G., Friera, A. M., White, K., Young, C., Basco, R., Lamba, M., Wells, F., Ankala, R., Dowdle, W. E., Lin, A., Egenberger, K., Rukstalis, J. M., Millman, J. R., Connolly, A. J., Deuse, T., & Schrepfer, S. (2023). Human hypoimmune primary pancreatic islets avoid rejection and autoimmunity and alleviate diabetes in allogeneic humanized mice. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.adg5794

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.